Familial combined hyperlipidemia (FCH) subjects exhibit high apoA-II levels, hypercholesterolemia, increased body fat, insulin resistance, altered free fatty acid metabolism, as well as a high rate of coronary artery disease [87]. Here, APOA2 is linked to coronary artery disorder.